EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark OTEEB was filed as Word mark on 06/12/2019 at the European Union Intellectual Property Office. The current status of the mark is "Application withdrawn".
| Trademark form | Word mark |
| File reference | 018081742 |
| Application date | June 12, 2019 |
| Publication date | September 6, 2019 |
Trademark owner
Lilly Corporate Center
46285 Indianapolis,
US
46285 Indianapolis,
US
Trademark representatives
Bedford House, John Street
WC1N 2BF London
GB
Objection / Complaint
goods and services
5
Pharmaceutical preparations namely, pharmaceutical preparations for the treatment, diagnosis and/or prevention of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders; pharmaceutical preparations for the treatment, diagnosis and/or prevention of diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, headaches, heart failure, hypoglycemia, inflammation and inflammatory diseases and disorders; pharmaceutical preparations for the treatment, diagnosis and/or prevention of inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders; pharmaceutical preparations for the treatment, diagnosis and/or prevention of migraines, multiple sclerosis, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, obesity, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, Sjogren's syndrome, sleep disorders, spondyloarthropathy and ulcerative colitis; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases and of oncology and of pain; pharmaceutical preparations
ID: 11018081742